The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods

Stephanie Deeds(University of Cincinnati), Opeolu Adeoye(IDEO (United States)), James C. Grotta(Memorial Hermann), Andrew D. Barreto(UCLA Medical Center), Jordan Elm(Medical University of South Carolina), Scott Berry(Queen's University), Claudia S. Moy(National Institute of Neurological Disorders and Stroke), Colin P. Derdeyn(Neurological Surgery), Pooja Khatri(Yale University), Joseph P. Broderick(University of Cincinnati), Scott Janis(National Institutes of Health)
International Journal of Stroke
December 9, 2020
10.1177/1747493020978345
Cited by 48

Related Papers

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2019|7.2k
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2018|5.5k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
|New England Journal of Medicine|2011|1.9k